![]()
展鹏
-
教授
博士生导师
硕士生导师
- 性别：男
- 毕业院校：山东大学
- 学历：博士研究生毕业
- 学位：医学博士学位
- 在职信息：在职
- 所在单位：药学院
- 入职时间： 2010-07-26
- 办公地点：山东大学国家大学生科技园（二环南路）3号楼14层1435房间
- 联系方式：13793130595
- 电子邮箱：zhanpeng1982@sdu.edu.cn
访问量：
-
[381]
展鹏 , 康东伟 and 刘新泳.
Discovery of a propionamide prodrug of K-5a2 with improved aqueous solubility and oral bioavailabili.
2018.
-
[382]
展鹏 , 康东伟 and 刘新泳.
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influen.
J Med Chem.,
2018.
-
[383]
展鹏 , 康东伟 and 刘新泳.
药学专业无机化学教学方法的改良.
《药学教育》,
2018.
-
[384]
展鹏 , 康东伟 and 刘新泳.
Discovery of bioactive molecular via a privileged scaffold repositioning approach..
2018.
-
[385]
展鹏 , 康东伟 and 刘新泳.
The discovery of novel diarylpyri(mi) dine derivatives with high level activity against a wide varie.
Bioorganic & Medicinal Chemistry,
2018.
-
[386]
展鹏 , 康东伟 and 刘新泳.
新型HIV-1 RNase H抑制剂的设计、合成与活性评价.
2018.
-
[387]
展鹏 and 刘新泳.
Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics..
Drug Discov Today.,
2018.
-
[388]
展鹏 and 刘新泳.
Discovery of novel phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-.
2018.
-
[389]
刘新泳 and 展鹏.
抗艾滋病药物设计新策略：多靶点及多价态结合配体.
《中国药物化学杂志》,
23,
406,
2013.
-
[390]
刘新泳 and 展鹏.
Heterocycle-thioacetic Acid Motif: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharma.
Current Pharmaceutical Design,
2013.
-
[391]
刘新泳 and 展鹏.
Design, synthesis and acetylcholinesterase (AChE) inhibition assay of novel 9-(1-(substituted-benzy.
E-JOURNAL OF CHEMISTRY,
2013.
-
[392]
刘新泳 and 展鹏.
The HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors (Part V): Capravirine and Its Analogues.
Curr Med Chem. 2012;19(36):6138-49.,
2012.
-
[393]
刘新泳 and 展鹏.
Discovery of novel pyridazinylthioacetamides as potent HIV-1 NNRTIs using a structure-based bioisost.
Med. Chem. Commun., 2013,4, 810-816.,
2013.
-
[394]
刘新泳 and 展鹏.
Multivalent agents: a novel concept and preliminary practice in anti-HIV drug discovery.
Curr Med Chem. 2013 Feb 1;20(6):815-32.,
2013.
-
[395]
刘新泳 and 展鹏.
Privileged Scaffolds or Promiscuous Binders: A Glance of Pyrrolo[2,1-f][1,2,4]triazines and Related .
Curr Pharm Des. 2013;19(8):1528-48.,
2013.
-
[396]
刘新泳 and 展鹏.
Arylazolyl(azinyl)thioacetanilides. Part 10: Design, synthesis and biological evaluation of novel su.
《Bioorg Med Chem.》,
20,
5527,
2012.
-
[397]
刘新泳 and 展鹏.
Rationally designed multitarget anti-HIV agents.
Curr Med Chem,
20,
1743,
2013.
-
[398]
刘新泳 and 展鹏.
以黄嘌呤氧化酶为靶点的新型非嘌呤类抗痛风及高尿酸血症药物研究进展.
《中国药物化学杂志》,
22,
403,
2012.
-
[399]
刘新泳 and 展鹏.
Benzimidazole Heterocycle as a Privileged Scaffold in Antiviral Agents..
Mini-Rev Org. Chem.,
9,
397,
2012.
-
[400]
刘新泳 and 展鹏.
Discovery of Novel 2-(3-(2-Chlorophenyl) pyrazin-2-ylthio)-N-arylacetamides As Potent HIV-1 Inhibito.
Bioorg. Med. Chem.,
20,
6795,
2012.
